Orthopaedic clinic - Musculoskeletal tumour outpatient service in CALHN

The Royal Adelaide Hospital (RAH) musculoskeletal tumour outpatient clinic is a part of The South Australian Sarcoma and Bone Tumour Unit, it is a statewide service and a dedicated clinician is located at the RAH. 

Please view the Bone Tumor Unit at Flinders Medical Centre page for more information.

The aim of the service is to improve outcomes for all patients with bone cancers, sarcomas and metastatic tumours. We want to ensure that all patients have access to the highest quality care. This includes access to surgical teams with appropriate sarcoma-specific and anatomic site knowledge as well as access to specialist paediatric, clinical and medical oncologists who have a particular interest and knowledge in sarcoma management with access to systemic treatment and radiotherapy.

Specialist Sarcoma multidisciplinary team is responsible for assessment, diagnosis and treatment including surgical management, oncology and radiotherapy for soft tissue sarcoma and bone sarcoma.

Appointment location

Royal Adelaide Hospital (RAH)

Outpatient Department, Level 3G.
Royal Adelaide Hospital
Port Road SA 5000


Dr Jakub Jagiello  

Dr Jagiello is a consultant orthopaedic surgeon working at the Royal Adelaide Hospital, The Women's and Children’s Hospital and Flinders Medical Centre; as part of the The South Australian Sarcoma and Bone Tumour Unit. His specialist interest include the treatment of arthritis and degenerative joint disease including hip and knee replacement surgery, cartilage injury, together with all aspects of revision surgery.

Other specialist interests include bone and soft tissue sarcoma, together with metastatic cancer surgery. The team strive to deliver the highest standard of modern orthopaedic care, from consultation through to surgery and rehabilitation.

The unit deals with some of the most complex cases of bone and soft tissue tumours as well as complex revision joint surgery; they are recognised nationally and internationally for achieving the best patient outcomes, developing and implementing new treatment strategies and continued translational research.